Health Canada has decided to put on hold a new product licensing requirement under which manufacturers of medical devices with a drug component were required to provide the Drug Identification Number (DIN) of the product’s medicinal component to establish that it meets acceptable standards of safety, efficacy and quality 1
...
Please Login to read the full article.
